The studies reported herein were, with one exception, all done in the same laboratory. They were intended to delineate a toxicologic profile for these three goldcontaining compounds, on which assessment of their safety for human clinical trials would be based.
from the next lowest dose group was examined until a no-effect dose was found or the lowest dose group was reached.
Six-Week Toxicity Test of SK&F 36914 PROCEDURE. Groups of 159 and 158 rats were given single daily doses of tragacanth alone, 1.78 (l.O), 8.9 (5.0) or 17.8 (10.0) mg/kg/day of the compound suspension by gavage for 42 days. The high dose was increased to 23 (12.9), 28 (15.7) and 35 (19.7) mg/kg/day on days 15, 22, and 36, respectively.
RESULTS.
The rats developed loose stools or diarrhea, most pronounced with the initial doses, dose-related increased salivation, and increased muscle tone. They became more easily irritated when handled. Alopecia occurred more commonly in the treated rats.
Food consumption was not affected, but except for the low-dose female group, the average body weight of each of the treated groups was less than that of the controls. The high-dose female group reached 90%, and the males 77%, of the group average body weight reached by the controls at the end of the study.
The packed cell volume (PCV) of the erythrocytes was decreased slightly (about 4%), in the high-dose group compared to the controls. The change is considered to be treatment-related but not of clinically significant extent.
The alkaline phosphatase and glutamic pyruvic transaminase activities were slightly decreased in the treated groups. Similar slight decreases occurred in other studies in both rats and dogs. No toxicologic significance is attached to this change. In fact, no clinical abnormality is known to be associated with such decreases in plasma enzyme activity.
The only gross lesion attributed to administration of the compound was red to brown streaks on the gastric mucosa, involving the fundic and pyloric areas. Their incidence was dose-related. Histologically, the streaks were superficial gastric erosions that extended up to ?4 of the way through the mucosa and covered up to 5% of its surface. Fresh erosions as well as all stages of healing were seen.
Conclusion
The main toxic sign of SK&F 36914 in rats after 6 weeks of dosing was loss of body weight.
Six-Month Toxicity Test of SK&F 36914 PROCEDURE.
Four groups of 15 female and 15 male rats were given single daily doses of tragacanth alone or 1.8 (l.O), 4.5 (2.5) or 12 (6.7) mg/kg of SK&F 36914 suspension by gavage for 182 days.
RESULTS.
Salivation, increased muscle tone, vocalization when handled, alopecia and occasional soft stools occurred in a dose-related incidence.
Food consumption was not affected, but body weight gain was decreased in the middle-and high-dose groups in a dose-and time-related manner. The high-dose I5 females reached 8 1% and the males 74% of the body weights attained by the controls at the end of the study.
The only treatment-related lesions were in the stomach and kidney. The gastric mucosa had the same kind of focal superficial erosions as were seen grossly in the 6week study. The incidences found by examining histologically 3 separate sections of stomach per animal from the control, low, middle and high dose groups, were 0/30, 0/30, 12/30 and 26/30, respectively.
In the kidney, the cortical tubular epithelial cells were enlarged (cytomegaly). A dose-related nuclear enlargement (karyomegaly) was more prominent than the cytoplasmic component. The nuclei were pleomorphic, often hyperchromatic, and sometimes multinucleated. Very rarely, intranuclear eosinophilic inclusions were present. These lesions are described in detail on page 53.
Conclusion
After 6 months of treatment, the main effect, in addition to the decreased body weight, was renal tubular cell karyomegaly.
One-Year Toxicity Test of SK&F 36914
PROCEDURE. Four groups of 20 female and 20 male rats were given single daily doses of tragacanth alone or 1.8,4.5 or 12 mg/kg of SK&F 36914 suspension by gavage for 366 days.
RESULTS. Drug-related salivation, tense muscles and soft stools occurred as in the 6-week and 6-month studies. The rats given the high dose developed an unkempt appearance with lackluster hair after 6 months of dosing. Food consumption was greater in the high-dose group, but dose-related decreases in body weight gains occurred as in the 6-week and 6-month studies.
As in the 6-month study, dose-related tubular cell karyomegaly and cytomegaly occurred in the renal cortex. Rarely, eosinophilic intranuclear inclusion bodies were found in these tubular cells.
In addition, neoplasia of the cortical renal tubular epithelium (adenoma) occurred. * Most of the rats were killed for autopsy after 12 months of dosing, but some were held for varying intervals up to 10% months of a drug-withdrawal period. The overall incidence of adenomas was 0/38, 3/39, 6/37 or 8/37 for the control, low-, middleand high-dose groups, respectively.
Conclusion
After 12 months of treatment, the main effect was the occurrence of renal tubular adenomas.
*Since renal adenomas also occurred in the rats given SK&F D-39162 or gold sodium thiomalate, they are all described together in a separate paper (p. 53).
Repeated One-Year Toxicity Test of SK&F 36914
PROCEDURE. Two groups of 80 (409 and 408) rats each were given single daily oral doses of tragacanth alone or 12 (6.7) mg/kg of SK&F 36914 by gavage for 365 days. This study was done subsequent to the foregoing one of similar duration as a positive control for a I-year study of SK&F D-39162 (see p. 21). Some rats died during the study. and some were killed at prescribed intervals to determine the progression of renal lesions.
RESULTS. The dose was the same as the high dose in the previous 1-year study (p. 15), and as expected, the same general changes were seen. However, the mortality rate was higher in the present study. Between 6 and 12 months, 3/29 treated females and 11/27 treated males died in this study, whereas only 1/20 treated females and 2/18 treated males given the same dose in the previous study died. Ileocecocolic ulcers, which occurred only in the present study, were considered to be the cause. The ulcers occurred in 30% of the rats dosed with SK&F 36914.
The ileocecocolic lesions were a striking and unexpected finding. Curiously, they did not occur in the first 1-year study of SK&F 36914, in which the same strain of rats was given the same dose, of the same batch of compound, in the same laboratory.
The ileocecocolic lesion could often be palpated through the body wall as a firm mid-abdominal mass. At autopsy, the mass was found to be comprised of scar tissue, within which were intestines and omentum, intimately intertwined and adherent. By careful dissection and opening of the intestines, the site of the lesion could be localized at the junction of the ileum, cecum and colon. A well-demarcated area of black discoloration was present on the mucosal surface of the intestine (Figs. 1-4 ). This lesion was usually excavated, like a typical ulcer, but in some cases was a raised, black nodule.
Histologic examination of these lesions in various stages of development showed coagulative necrosis of the mucosa to be the initial lesion ( Fig. 9 ). These small, circumscribed lesions gradually extended into the adjacer?t unaffected mucosa to reach a considerably larger size. In these ulcers, the affected tissue was localized, and demarcated from the normal tissue by a prominent zone of purulent inflammation ( Figs. 5, 6 ). In the course of enlargement to ulcers, the mucosa underwent necrosis affecting the tips of the villi (Fig. 7) . In later stages, an underlying zone of pyogenic granulation tissue was present, often replacing all of the intestinal wall. Sometimes, the lesion was excavated so as to have the appearance of an ulcer (Fig. 5) ; while in others, the accumulation of necrotic debris resulted in the formation of a nodule (Fig. 8) . Colonies of bacteria were in the necrotic tissue. Palisades of rod-shaped, slightly curved bacteria were often immediately adjacent to, and sometimes apparently in, the intestinal epithelial cells.
Discussion
The initial histologic change appeared to be necrosis of the mucosal epithelium, which spread so slowly into the muscle wall that fibrous granulation tissue usually formed and prevented rupture into the peritoneal cavity. In the advanced lesion, the Section through a 1.0 cm diameter ulcer in a rat that died on day 315. The mucosa has been lost from the central part, but the continuity of the intestinal wall is maintained by a patch of inflammatory reaction products. Fig. 6 Magnification from the right side of the ulcer in Fig. 5 , showing pale necrotic tissue at the upper left, an adjacent dense zone, and decreasing density below and to the right.
Inset: Magnification from the dense zone, in which neutrophils are accumulated in large numbers. Fig. 7 : Magnification from the upper center of Fig. 6 showing necrosis of the mucosa. The epithelium on the left is sloughed from the tips of the villi but is intact deeper in the mucosa. There is a gradual transition to complete absence of epithelium on the right.
Fig. 8
Histologic appearance of a 2 cm diameter greenish-black nodule at the ileocecocolic junction of a rat that died on day 331. The nodule is an accumulation of fibrin, serum and necrotic debris, bounded by normal mucosa. The dark line in the lower center is the zone of inflammation between the necrotic and viable tissue. The underlying zone is pyogenic, fibrous granulation tissue.
Fig. 9:
Histologic appearance of an early stage of the lesion, at the ileocecocolic junction of a clinically normal rat killed after 6 months of dosing. The darker zone on the left is composed of bacteria on the luminal surface, beneath which is a zone of inflammation and remnants of mucosal epithelium. The inflammation extends slightly into the submuwsa but the muscular wall and the muwsa on each side are normal. The lesion is circumscribed above and below by unaffected muwsa.
intestinal wall was completely replaced with scar tissue, resulting in the firm masses, palpable grossly. The lesion was almost always localized to the ileocecocolic junction.
The lesion resembles the "necrotic enteritis" and "button ulcers" of swine3. A spontaneous lesion of rats, chronic ulcerative cecitis, is morphologically similar but is limited to the cecum4.
One of the possible reasons for the presence of the ulcers in this study and its absence in the previous one might be a difference in the microbial flora between the 2 groups of rats. Bacterial cultures of the intestinal contents at the ileocecocolic junction were collected to make the only comparison possible, viz., between the affected and unaffected rats in the present study. No difference was found between the kinds of bacteria present in either group. Three cultures of Escherichia coli, isolated from the lesion, were submitted to the National Animal Disease Center in Ames, Iowa. Dr. Harley Moon reported2, "I conclude your strains do not have the ability to invade epithelium which is characteristic of some enteropathogenic E. coli, and that it is unlikely these strains contribute to the lesions in the rats via invading and destroying intestinal epithelium."
Nevertheless, interaction with the microflora remains a good possibility for at least part of the etiology. Kent et al.' produced similar lesions in the small intestine of the rat by giving a single dose of indomethacin (a non-steroidal anti-inflammatory agent) either intragastrically or intramuscularly. They found an overgrowth of "cecal-type organisms" in the small intestine. Preventing bacterial overgrowth by antibiotics protected against the lethal effects of indomethacin.
Although the lesion occurs acutely, it is of interest that ulcerating inflammation involving principally the colon, is caused by another heavy metal, in mercurial poisoning of human beings?
The karyomegaly of the renal tubular epithelial cells and rare intranuclear inclusions seen in the previous study also occurred in this one. A renal tubular cell adenoma, was found in 2 of the 26 females but in none of the 16 males that lived to the end of the study.
Conclusion
After 12 months of administration, the main effects were the occurrence of ileocecocolic ulcers and of renal adenomas.
Three-Month Toxicity Test of SK&F D-39162
PROCEDURE. Four groups of 30 rats each (I50 and 158) were given single daily doses of tragacanth alone or 3.6 (l.O), 12.0 (3.5) or 36.0 (10.0) mdkg of SK&F D-39162 suspension by gavage for 93 days. This study was done at Bio/dynamics Inc., East Millstone, New Jersey.
RESULTS.
Dose-related salivation, tenseness and struggling during dosing, and soft stools occurred. Food consumption was not affected but the gain in body weight was decreased.
The blood hemoglobin concentration and the erythrocyte PCV were slightly lower in the high-dose than in the control group. The alkaline phosphatase activity in the serum was decreased in a dose-related manner.
No compound-related lesion was seen.
Conclusion
The main toxic effect after 3 months of dosing was decreased body weight.
OneYear Toxicity Test of SK&F D-39162
PROCEDURE. Dosing was initiated in 4 groups of 80 (409 and 40~3) rats given a single daily dose of tragacanth alone or 3.6 (I), 12 (3.5) or 23 (6.7) mg/kg of drug suspension by gavage. (59 and 5d) were killed 4%, 6, and 9 months after commencement of dosing for histologic examination of their kidneys. The remaining rats were autopsied after 364 or 365 daily doses.
Ten rats
RESULTS. Dose-related salivation began after the first dose and recurred throughout the study. The incidence increased to about 80% in the low-dose group and to 100% in the other 2 dose groups. Initially the salivation lasted 15-20 minutes after dosing, but by the end of the study a few rats receiving the high dose salivated for 4-5 hours.
Soft feces occurred sporadically in a few high-dose rats. Some high-dose rats developed increased muscle tone and excessive urination during dosing. The highdose males became somewhat emaciated and poorly groomed during the last half of the study.
A slight drug-related anemia and leukocytosis occurred. These were considered to be secondary to ileocecocolic or other lesions rather than a direct toxic effect.
A few rats died during the study in all groups, as is our usual experience, but a disproportionate number of these were males in the high-dose group. The males that died in the control, low-, mid-, and high-dose groups respectively were 1, 1, 2, and 15. The unusually high number of deaths in the high-dose males was attributed to the occurrence of ileocecocolic ulcers, similar to the ones occurring in the rats dosed during the same time span with the other gold-containing compound (p. 16). These ulcers occurred in 6% of the middle-dose and 21% of the high-dose rats but not in any rat in the control or low-dose group.
An abscess of the bile duct occurred in 1 rat in the high-dose group. Such a lesion did not occur in any control animal and has not occurred in several thousand rats examined in this laboratory over the last 10 years.
Renal tubular cell karyomegaly and cytomegaly occurred and were dose-and time-related. An adenoma of renal tubular cells occurred in 2/25 female rats dosed for 12 months with the highest dose. No adenoma was found in males, but a high proportion had died before the end of the study.
Conclusion
The drug-related lesions were renal tubular cell karyomegaly, cytomegaly and adenomas, gastric erosions, and ileocecocolic ulcers.
One-Year Toxicity Test of Gold sodium Thiomalate
PRoceDuRe. Two groups of 80 (409 and 406) rats were injected intramuscularly once a week in alternate rear legs with 6 (3) or 12 (6.1) mg/kg of gold sodium thiomalate. The control rats were a group which received tragacanth only, in a concurrently run I-year study of SK&F D-39162 (p. 21) and also served as the controls for this study. Ten test rats (59 and 56) were killed 4%. 6 and 9 months after the commencement of dosing for histologic examination of their kidneys. These were compared with the 10 controls also killed at these intervals.
RESULTS. The rats tolerated the injections without clinically apparent local imtation. Beginning in the 8th week they became tense and hypersensitive to handling.
The red blood cell count, packed cell volume (PCV) and hemoglobin concentration decreased slightly compared to uninjected controls. For example, the PCV decreased 4% in the 12 mg/kg group and 3% in the 6 mg/kg group.
Renal tubular cell karyomegaly, like that seen in the rats dosed orally with the two other gold-containing compounds (pp. 15 and 21), occurred. It was slight after 4% months of dosing, slight to moderate after 6,9, and 12 months. Histologically, a renal cortical cell adenoma occurred in 1/16 of the females but in none of the males.
A 21-Month Nephrotoxicity Study of Cold Sodium Thiomalate PROCEDURE. Thirty-two (169 and 166) rats were injected once week4 in alternate rear legs with 2 ( I ) mg/kg of gold sodium thiomalate for 46 weeks and then once duib with 6 (3) mg/kg for 330 days. The kidneys of the 89 and 76 rats that survived for the 21-month period were examined histologically. Subserial sections were prepared until an adenoma was found histologically or until all of both kidneys had been examined.
RESULTS. The only clinical effect attributed to the drug was a slight transient (~1 0 % ) decrease in body weight when the dose was increased during the 47th week. No evidence of neoplasia of the renal cortex was seen grossly. Histologically, all of the rats had marked karyomegaly of the renal cortical tubular epithelial cells. Cystic tubules with thick, irregular, hypercellular walls (considered a pre-neoplastic change) were frequently seen. Renal adenomas, sometimes multiple ones, were found in 8/8 females and 3/7 males surviving 2 1 months.
Conclusion
The administration of gold sodium thiomalate evoked similar renal alterations as did the other 2 gold-containing compounds, viz., renal tubular cell karyomegaly and adenomas in the cortex.
